1,25-Dihydroxyvitamin D in plasma is measured by competitive protein-binding assay after isolation from plasma. The present method is improved, as compared with those hitherto described, with regard to receptor preparation, isolation of vitamin D metabolites from plasma, and procedure for the competitive protein binding. Receptor preparation from healthy rather than rachitic chicks, to (6), mass-fragmentography (7), and radioimmunoassay (8-10). Bioassay and mass-fragmentography are not very suited for routine analysis of 1,25(OH)2D in plasma, because these methods are either time consuming or require too-large volumes of plasma. Both radioreceptor analysis and radioimmunoassay can be adapted for the analysis of many samples. The advantage of the radioreceptor assay is that the receptor is much easier to obtain than is antiserum for use in the radioimmunoassay.
measurement in human blood will be of great value in the search for possible disorders of vitamin D metabolism in patients with calculous disease (2) , decreased renal function (3), and (or) disorders of bone metabolism (4) . A prerequisite to the analysis for vitamin D metabolites in clinical investigation is the availability of a relative simple and fast procedure for their measurement.
Previous techniques used fori,25(OH)2Dassay arebioassay (5) , radioreceptor assay (6), mass-fragmentography (7) , and radioimmunoassay (8) (9) (10) . Bioassay and mass-fragmentography are not very suited for routine analysis of 1,25(OH)2D in plasma, because these methods are either time consuming or require too-large volumes of plasma. Both radioreceptor analysis and radioimmunoassay can be adapted for the analysis of many samples. The advantage of the radioreceptor assay is that the receptor is much easier to obtain than is antiserum for use in the radioimmunoassay.
In this report we describe a method for measurement of 1,25(OH)2D based on theprocedureofEisman eta!. (6) , with a simple isolation procedure and a modified competitive protein-binding procedure. Moreover, we describe a procedure for preparing receptor protein in high yield and with a high binding capacity. These modifications result in a relatively convenient and fast assay with high precision and a low detection limit. Also, this procedure will be suited for use in isolation of other important vitamin D metabolites inthesame run. (spec. acty. 68 kCi/ mol), and 1a,25-dihydroxy [23,24(n) SHJcholecalciferol (spec. acty. 82 kCi/mol) were purchased from the Radiochemical Centre, Amersham, U.K., and stored in absolute ethanol at -20 #{176}C. i,25(OH)2[3H]D3, used to monitor recovery during plasma purification, was purified by liquid chromatography on a Nucleosil 10-NO2 column, developed with n-hexane/ isopropanol/water (90/10/0.35 by vol) at a flow rate of 2 mL/min.
Materials

Vitamin D Metabolites
Reagents
All solvents forextraction and "high-performance" liquid chromatography (HPLC) were of analytical grade and were used without further purification.
Dextran (Grade C) was obtained from BDH Chemicals, Poole, U.K. Activated charcoal (analytical grade) was from 10-NO2 for HPLC columns was obtained from MacheryNagel, Duren, F. R. G. Conical polyethylene tubes (13 
Animals
Hybro chickens were raised at the "Spelderholt Institute At four weeks of age the chickens were killed for receptor preparation.
Methods
Preparation of Cytosol Receptor
Batches of 12 chickens were killed by decapitation. The duodenal loops were removed and rinsed with 5 mL of phosphate buffer (50 mmol/L potassium phosphate, 50 mmol/L potassium chloride, 1 mmol/L dithiothreitol, pH 7.4). The mucosa was scraped from the serosa and washed three times with five volumes of phosphate buffer. The mucosa was then homogenized in one volume of buffer with three strokes of a Potter-Elvejhem Teflon/glass homogenizer. The whole procedure was carried out at 4 #{176}C within 45 mm. After centrifugation in a 10 X 10 mL titanium head at65 000 rpm (MSE 75 ultracentrifuge, 2 #{176}C, total running time 35 mm, max. g value 300 000), the supernates, including the lipid layers, were pooled, divided into 2-mL aliquots, and subsequently frozen in liquid nitrogen. These aliquots were lyophilized overnight and stored under the original freeze-drying vacuum at -40 #{176}C. The protein content of each batch was measured according toLowryetal.
(11).
Binding Properties of the Cytosol Receptor The influence of 0.6 and 1.2 g of gelatin per liter in the incubation buffer (see CPB section below) was examined. Extraction of Plasma To 5 mL of plasma was added 6000 dpm of 1,25(OH)2[3H]-D3 in 50 sL of ethanol. After equilibration at room temperature for 30 mm, the plasma was extracted with 25 mL of nhexane/isopropanol/n-butanol (93/3/4 by vol). The mixture wasvortex-mixed during 3 min and the phases were separated by centrifugation. The aqueous phase was frozenin liquid nitrogen.
The organicphase was then decantedintoanother extraction tube, where itwas taken todryness in a stream of nitrogen.
Purification of the Plasma Extract
The residue of the plasma extract was dissolved in 210 ML of n-hexane/isopropanol (9/1 by vol), transferred to low-volume inserts of the automatic HPLC sample processor, and injected onto a Nucleosil 10-NO2 column (12 X 0.46 cm) fitted with a Nucleosil 10-NO2 precolumn (4 X 0.46 cm). 1,25(OH)2D was separated from other vitamin D metabolites and unknown interfering compounds by gradient elution with two solvents (solvent A and B). Solvent A consisted of a mixture of n-hexane ethanol/isopropanol/water (80/20/0.7 by vol). Solvent B was n-hexane. Starting with 100% solvent B at a flow rate of 4 mL/min, lipid contaminants were removed from the column. The vitamin D metabolites were then eluted by gradually increasing the proportion of solvent A to 50%. Concurrently, the flow rate was reduced to 2 mL/min. Remaining interfering compounds were removed with 100% solvent A at a flow rate of 4 mL/min. A detailed illustration of the program is given in Figure 1 .
Because the first injections of plasma extracts on a new column cause a considerable decrease in the retention times of the vitamin D metabolites, accompanied by poorer resolution, every new column was primed by injection of 10 extracts of 5-mL aliquots of rejected plasma.
After each (6) . To obtain a high binding without the need for a long incubation, we chose an incubation at 20 #{176}C for 75 mm.
As can be seen in Figure 2 , prolonged preincubation of cy- 
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Results
Receptor Preparation
We compared receptor prepared from duodena of fourweek-old rachitic chickens with that from nonrachitic chickens. The use of nonrachitic animals provided at least twice as much receptor protein as rachitic chickens because the nonrachitic chickens grew much faster. Moreover, several of the rachitic chickens died before they were four weeks old.
Shortening the total ultracentrifuge running time to 35 mm doubled the binding capacity of the preparation. In this way, 12 four-week-old, healthyHybro chicksprovidedabout 1.7 g of lyophilized receptorprotein, sufficient forabout 4000 incubations.
When stored lyophilized at -40 #{176}C under the original freeze-drying vacuum, no loss of binding potency was observed during one year. tosol with receptor at 0 #{176}C caused substantial binding of
1,25(OH)2[3H]D3
to the receptor,which increasedwith preincubation time. The differences in binding that existed after the preincubation still partly persisted after various incubation times at 20 #{176}C in the presence of 40 pg of unlabeled 1,25(OH)2D3. An incubation time of 40 mm at 20 #{176}C seems to be sufficient to obtain nearly equilibrium conditions. To be completely sure of equilibrium conditions, irrespective of varying preincubation times, we used an incubation time of 75 mm at 20 #{176}C. Under these circumstances short preincubation times (1-17.5 mm) were re-examined. The final binding appeared to be constant when preincubation time was not longer than 5 mm. Preincubating more than 5 mm resulted in an increase of the final binding, indicating partly irreversible binding of 1,25(OH)2[3H]D3 during the preincubation. To prevent differences in binding within a series of assay tubes, we limited the preincubation time to less than 5 mm.
Extraction
The one-step extraction procedure with the new solvent resulted in a high extraction efficiency. The recovery of 1,25(OH)2[3H]D3 added to 5 mL plasma was 89.7% (SD 1.3%) (n = 10).
Under the same circumstances, 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were recovered from plasma in a highyield(94% and 89%, respectively).
Purification of the Plasma Extract
The Nucleosil 10-NO2 packing material, used inpreparing the HPLC columns,showed relatively shortretention times for the vitamin D metabolites studied. In addition, this material showed good compatibility with repeated gradient elution of plasma extracts. More than 100 plasma extracts could be purified with one column.
The qualityofthe separationprocedurewas determined by fractionating the complete eluate from the HPLC after injection of a plasma extract. The fractions tested for displacement activity in the 1,25(OH)2D assay showed four peaks ( Figure 3 ). The first and second peak coeluted with 25(OH)-[3H]D3 and 1,25(OH)2[3H]D3, respectively; the third peak probably consisted of an impurity introduced by the purification procedure, because it was also present in the HPLC profile of a water extract. The last peak was caused by a rather polar compound present in plasma extracts that displaces 1,25(OH)2[3H]D3 from its intestinal cytosol receptor. The compound could be removed from the column with 100% solvent A. Under the conditions we used, the whole HPLC run took place within 55 mm. Re-equilibratmun of the column with solvent B took another 10 mm. The isolation procedure described yielded well-purified fractions with 1,25(OH)2D. Water blanks carried through the whole procedure contained no displacement activity in the 1,25(OH)2D assay (less than 2 pg per tube).
The one-step purification resulted in very reproducible and high recoveries.
Overall recovery after HPLC for 1,25(OH)2-[3HJD3 was 78.1% (SD 4.7%).
Competitive
Protein Binding High intra-assay reproducibility of the assay could be attained by observing the following details:
1. The ethanol content of the incubation mixture should be exactly the same for every incubation tube. For that purpose evaporation of the ethanol in which the samples and standards were dissolved was minimized by adding 100 ML of phosphate buffer to the tubes before samples and standards were added.
Receptor and 1,25(OH)2[3H]D3
were combined before addition to the assay tubes. This resulted in a more stable 3. Separationof bound from free1,25(OH)2D3 was very conveniently carried out with dextran-coated charcoal; this resulted inbetter reproducibility ofstandard curves than does the polyethylene glycol method.
The procedure developed appeared to be convenient and reliable, with sensitive standard curves (Figure 4a ).
When the reciprocals of specific binding of the standards were plotted against the amount of unlabeled 1,25(OH)2D3, straight lines resulted, which means that the curves correspond with theoretical isotope-dilution curves (Figure 4b) . The detection limit of the assay (when expressed as two standard deviations of the binding without unlabeled 1,25(OH)2D3) was 1-2 pg per tube.
Precision
of the Assay The intra-and interassay CVs were determined by analyzing a pool of plasma from 20 healthy subjects eight times Within-day 9.0 Extraction Endogenon. Pooledplasma of 20 healthy subjects wasassayed eightfold on six different days. Th between-day CV hasbeen derived from the mean 1,25(OH),D concentrations for the sixdIfferent days.
on six different days (Table 1) (Table 2) .
Concentrations in Plasma
Individual values for plasma from the subjects contributing to the plasma pool averaged 51.7 (SD 10.8) ng/L (n = 20; range 32.0-78.5 ngfL). Plasma 1,25(OH)2D concentrations measured 3, 6, and 7 ng/L in three anephric patients.
Discussion
Receptor Preparation
Hitherto, various protein preparations have been used for the competitive protein-binding assay of 1,25(OH)2D: cytosol receptors from chicken duodenum (6, (12) (13) (14) and antibodies raised against 1,25(OH)2D3 (8) (9) (10) . With the use of receptor protein, problems were encountered from the slight stability (6, 12, 15, 16) (Figure 3) . Nevertheless, our HPLC procedure provided a good separation of all vitamin D metabolites studied. This will be discussed in forthcoming reports.
Retention times of the vitamin D metabolites were constant enough that the HPLC procedure could be mechanized, which offered the opportunity to carry out sample purification overnight. 
Competitive Protein Binding
Plasma Samples
Concentrations of 1,25(OH)2D reported in plasma previously (Table 3) were generally lower than the concentrations (9) 20 (20) 33.4 (6.4) 16 (22) 35 (3) ? (24) 34 (11) Here SEM. b Not specified.
we found in healthy subjects. Possible explanations for the divergent values that have been measured might be geographical, nutritional, orracial differences intheinvestigated populations or the use of different purification and assay procedures, including systematic errors owing to extremely diluted standard solutions. Moreover, the small size of our study population also might account for the differences observed. The 1,25(OH)2D concentrations measured in the three anephric subjects were very low but significantly different from zero. Until now, 1,25(OH)2D in anephric subjects was reported to be undetectable (8, 12, 14, (19) (20) (21) (22) . The detection limit of these earlier assays, however, was 4-10 ng/L. Gray et al. (23) reported the presence of a compound in the plasma of anephric subjects treated with dihydrotachysterol that interfered with the 1,25(OH)2D measurement. The three subjects we examined had no dilsydrotachysterol therapy and had not received blood transfusions for at least four weeks. Whether the measured concentration of 1,25(OH)2D represented extrarenal production, intake of exogenous 1,25(OH)2D in some way, or an artefact remains to be established.
We conclude that our assay procedure has high precision and a low detection limit. The purification procedure is potentially suited for the analysis of other vitamin D metabolites and can be automated. The rather large number of plasma or serum samples that can be processed this way makes it an attractive assay for clinical application.
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